The clinical diagnosis value and significance of serum sH2a level on early hepatic fibrosis degree / 中华实验和临床病毒学杂志
Chinese Journal of Experimental and Clinical Virology
; (6): 57-61, 2017.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-807983
Responsible library:
WPRO
ABSTRACT
Objective@#We aimed, in our prospective study, to assess the predictive value of serum non-invasive and biochemical markers for clinical diagnosis of significant fibrosis (including early stages).@*Methods@#We measured sH2a levels in serum, comparing with routine liver function markers. We compared blindly pretreatment serum samples from a cohort of hepatitis B patients without non-alcoholic fatty liver disease(NAFLD), which had histological grades of liver fibrosis, with NAFLD individuals and CHB with NAFLD patients. Statistical analysis was by Student′s t test, and receiver-operating characteristic (ROC) curves were drawn.@*Results@#ROC curves showed that serum sH2a had greater diagnostic performance than routine liver function markers compared with histological grades of liver fibrosis(S0, S1-2, S3-4). ROC curves showed that using a sH2a cut-off point of 0.79 was with highest sensitivity as 63% and highest specificity as 80%. And sensitivity as 96.7% and specificity as 75.5% when using a sH2a cut-off point of 0.77.@*Conclusions@#sH2a has the potential to be a uniquely sensitive and specific novel marker for liver fibrosis and function.
Full text:
Available
Database:
WPRIM (Western Pacific)
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Language:
Chinese
Journal:
Chinese Journal of Experimental and Clinical Virology
Year:
2017
Document type:
Article